Daytrana is the MPH transdermal system of methylphenidate approved
Question Answered step-by-step Daytrana is the MPH transdermal system of methylphenidate approvedfor the treatment of ADHD in children aged 6 years and older. What is the difference in terms of the metabolism compared to the other formulations in this class? Health Science Science Nursing NURSING 6630S Share QuestionEmailCopy link Comments (0)


